Clinitech Laboratory Stock Performance
|
|
|
Clinitech Laboratory Company background
Founded in: 2010
Managing director: Jagdish Umakant Nayak
Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai. The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.Clinitech Laboratory are a provider of diagnostic and healthcare tests and services through chain of 8 diagnostic centers in and around Thane, Raigad and Navi Mumbai. Their Promoters have 30+ years of experience in diagnostic business. Promoters inspirational leadership has led Clinitech to be recognised as one of the trusted pathology lab in the region. They conduct more than 3 Lakh tests per year in NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited labs equipped with modern technology and highend equipment. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018. Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests. Clinical pathology is a medical specialty that focuses on the diagnosis of diseases and conditions through the analysis of bodily fluids and tissues. It includes various laboratory tests and techniques such as blood tests, urine analysis, and tissue biopsies to help healthcare professionals understand the underlying causes of a patients symptoms and guide treatment decisions. Clinical pathologists play a crucial role in interpreting test results and providing valuable information to aid in patient care. Imaging diagnosis or radiology involves imaging procedures such as Xrays and ultrasounds that help determine anatomical or physiological changes inside a patients body, thus assisting doctors in diagnosing. It includes more complex tests such as CT scans, MRIs, and highly specialized PETCT scans.The Company is proposing the Initial Offering by raising capital aggregating Rs 5.79 Crores and by issuing 6,02,400 Fresh Issue Equity Shares.
As of 29 Aug, 2025, Clinitech Laboratory share price is ₹52.5. The stock opened at ₹52.5 and had closed at ₹50 the previous day. During today’s trading session, Clinitech Laboratory share price moved between ₹52.50 and ₹52.50, with an average price for the day of ₹52.50. Over the last 52 weeks, the stock has recorded a low of ₹29.15 and a high of ₹98.99. In terms of performance, Clinitech Laboratory share price has declined by 23.9% over the past six months and has declined by 45.41% over the last year.
Clinitech Laboratory Fundamental
Market Cap (in crs)
11.98
Face Value
10
Turnover (in lacs)
1.26
Key Metrics
Qtr Change %
46.96% Fall from 52W High
28.5
Dividend yield 1yr %
0
Clinitech Laboratory Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
52.5
Current Price
5Day EMA
50.80
10Day EMA
48.30
12Day EMA
47.40
20Day EMA
44.60
26Day EMA
43.60
50Day EMA
44.10
100Day EMA
52.20
EMA
5Day SMA
50.60
10Day SMA
48.80
20Day SMA
41.40
30Day SMA
39.50
50Day SMA
40.30
100Day SMA
52.20
150Day SMA
61.90
SMA
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 2400 Rs | 2400 Rs |
Week Rs | 2000 Rs | 2000 Rs |
Month Rs | 7360 Rs | 8720 Rs |
Resistance & Support
52.50
Pivot
Resistance
First Resistance
52.50
Second Resistance
52.50
Third Resistance
52.50
Support
First Support
52.50
Second support
52.50
Third Support
52.50
Relative Strength Index
64.71
Money Flow Index
70.87
MACD
3.78
MACD Signal
2.35
Average True Range
2.82
Average Directional Index
36.14
Rate of Change (21)
61.04
Rate of Change (125)
-35.19
Clinitech Laboratory Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4.30 | 23.23 | 3.4 | 9.5 | 4.17 | -1.15% | 1.18% | -11.52% | -43.57% | -78.79% | 0.00% | 0.79 | 90.10 | 1.73 | |
Dolphin Medical Services Ltd. | - | 2.25 | - | - | - | - | - | - | - | - | - | - | - | - |
23.18 | 14.63 | 19.08 | 56 | 24.40 | -9.59% | -22.14% | -27.45% | -52.69% | -73.72% | 0.00% | 0.00 | 55.36 | 0.85 | |
8.88 | 6.22 | 6.53 | 22 | 8.83 | 11.56% | 17.93% | -47.02% | -47.02% | -47.02% | 0.00% | 0.00 | 25.27 | 1.05 | |
25.52 | 11.06 | 9.8 | 25.6 | 24.43 | 14.75% | 24.00% | 75.76% | 18.04% | -4.78% | 0.00% | 26.58 | 90.10 | 1.11 | |
Gian Life Care Ltd. | - | 14.85 | - | - | - | - | - | - | - | - | - | - | - | - |
Clinitech Laboratory Latest News
Clinitech Laboratory Share Price FAQs
How to buy Clinitech Laboratory shares?
You can easily buy Clinitech Laboratory shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Clinitech Laboratory ?
The 52-week high and low of Clinitech Laboratory share price is ₹98.99 and ₹29.15 as of 29/8/2025.
Please be aware that Clinitech Laboratory stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account